Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-24T22:46:37.480Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Pertussis in Healthcare Workers From a Pediatric Emergency Unit in France

Published online by Cambridge University Press:  02 January 2015

Jean-François Gehanno ,
Martine Pestel-Caron ,
Michèle Nouvellon  and
Jean-François Caillard
Jean-François Gehanno*
Affiliation:
Institute of Occupational Health, Charles Nicolle-Rouen University Hospital, Rouen, France
Martine Pestel-Caron
Affiliation:
Laboratory of Microbiology, Charles Nicolle-Rouen University Hospital, Rouen, France
Michèle Nouvellon
Affiliation:
Laboratory of Microbiology, Charles Nicolle-Rouen University Hospital, Rouen, France
Jean-François Caillard
Affiliation:
Institute of Occupational Health, Charles Nicolle-Rouen University Hospital, Rouen, France
*
Service Central de Médecine du Travail, Hotel Dieu de Paris, 1, place du Parvis Notre Dame, F-75004 Paris, France
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

After pertussis was diagnosed in July 1997 in a 55-year-old nurse (case) from a pediatric emergency unit who had a respiratory illness and paroxysmal cough for 5 weeks, an epidemiological investigation was initiated to determine if other healthcare workers (HCWs) from the same unit also had pertussis.

Design:

Interviews were conducted to assess symptoms occurring in the previous months. Two sera were collected 2 to 3 months apart for 59 of 61 HCWs of the unit. The IgG response to pertussis toxin was determined using Western blot assay.

Setting:

Pediatric emergency unit (61 HCWs) of a 2,500-bed university hospital.

Results:

There was a total of 10 (5 confirmed and 5 probable) cases of pertussis identified in this outbreak. Nine HCWs (15%) had results suggesting recent or acute pertussis. To avoid transmission to patients and other HCWs, all HCWs with cough were treated for 14 days with erythromycin, and those having acute cough were given a 5-day sick leave. Despite these measures, a new acute pertussis case was identified in a 41-year-old nurse, with a positive culture from nasopharyngeal aspirates. Thus, all HCWs in the unit were prescribed spiramycin for 10 days to prevent any further spread of pertussis.

Conclusion:

Pertussis should be considered a threat to HCWs who are in contact with children. For HCWs, diagnosis of pertussis should be made on a clinical basis, giving greater importance to sensitivity of diagnosis criteria, and on early bacterial identification by culture of the organism or by polymerase chain reaction.

Recommendations:

In case of pertussis in an HCW, all staff in the unit who have had unprotected and intensive contact with that person should be provided with macrolide treatment to stop any transmission to colleagues and to young patients. Furthermore, the possibility of providing these HCWs with acellular pertussis vaccines warrants further investigation.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 8 , August 1999 , pp. 549 - 552
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Bass, JW, Wittler, RR. Return of epidemic pertussis in the United States. Pediatr Infect Dis J 1994;13:343–345.Google Scholar
2.Baron, S, Bégué, P, Desenclos, JC. Evaluation épidémiologique, clinique, et microbiologique de la coqueluche en France en 1993-1994. Bull Epidemiol Hebd 1995;19:83–85.Google Scholar
3.Nennig, ME, Shinefield, HR, Edwards, KM, Black, SB, Fireman, BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672–1674.Google Scholar
4.Mink, CM, Cherry, JD, Christenson, P, Lewis, K, Pineda, E, Shlian, D, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464–471.Google Scholar
5.Kurt, TL, Yeager, AS, Guenette, S, Dunlop, S. Spread of pertussis by hospital staff. JAMA 1972;221:264–267.CrossRefGoogle ScholarPubMed
6.Steketee, RW, Wassilak, SGF, Adkins, WN, Burstyn, DG, Manclark, CR, Berg, J, et al. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 1988;157:434–440.CrossRefGoogle Scholar
7.Mink, CM, Sirota, NM, Nuget, S. Outbreak of pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med 1994;148:153–157.Google Scholar
8.Bolyard, EA, Tablan, OC, Williams, WW, Pearson, ML, Shapiro, CN, Deitchman, SD, et al. Guideline for infection control in healthcare personnel, 1998. Infect Control Hasp Epidemiol 1998;19:407–463.Google Scholar
9.Grimprel, E, Njamkepo, E, Bégué, P, Guiso, N. Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology. Clin Diagn Lab Immunol 1997;4:723–726.CrossRefGoogle ScholarPubMed
10.Strebel, PM, Cochi, SL, Farizo, KM, Payne, BJ, Hanauer, SD, Baughman, AL. Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Gin Infect Dis 1993;16:276–285.Google ScholarPubMed
11.Long, SS, Welkon, CJ, Clark, JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990;61:480–486.CrossRefGoogle Scholar
12.Halperin, SA, Bortolussi, R, Wort, AJ. Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol 1989;27:752–757.CrossRefGoogle ScholarPubMed
13.Schmitt-Grohé, S, Cherry, JD, Heininger, U, Uberall, MA, Pineda, E, Stehr, K. Pertussis in German adults. Clin Infect Dis 1995;21:860–866.Google Scholar
14.Müller, FMC, Hoppe, JE, Wirsing von König, CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microb 1997;35:2435–2443.CrossRefGoogle ScholarPubMed
15.Ewanowich, CA, Chui, LW, Paranchych, MG, Peppier, MS, Marusyk, RG, Albritton, WL. Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol 1993;31:1715–1725.CrossRefGoogle ScholarPubMed
16.Grimprel, E, Bégué, P, Anjak, I, Betsou, F, Guiso, N. Comparison of polymerase chain reaction, culture, and Western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol 1993;31:2745–2750.Google Scholar
17.Edelman, K, Nikkari, S, Ruuskanen, O, He, Q, Viljanen, M, Mertsola, J. Detection of Bordetella pertussis by polymerase chain reaction and culture in the nasopharynx of erythromycin-treated infants with pertussis. Pediatr Infect Dis J 1996;15:54–57.Google Scholar
18.Addiss, DG, Davis, JP, Meade, BD, Burstyn, DG, Meissner, M, Zastrow, JA, et al. A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991;164:704–710.Google Scholar
19.Christie, CDC, Glover, AM, Willke, MJ, Marx, ML, Reising, SF, Hutchinson, NM. Containment of pertussis in the regional pediatric hospital during the Greater Cincinnati epidemic of 1993. Infect Control Hosp Epidemiol 1995;16:556–563.Google Scholar
20.Weber, DJ, Rutala, WA. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 1994;15:411–415.Google Scholar
21.Weber, DJ, Rutala, WA. Pertussis: an underappreciated risk for nosocomial outbreaks. Infect Control Hosp Epidemiol 1998;19:825–828.Google Scholar
22.Edwards, KM, Decker, MD, Graham, BS, Mezzatesta, J, Scott, J, Hackell, J. Adult immunization with acellular pertussis vaccine. JAMA 1993;269:53–56.Google Scholar
23.Shefer, A, Dales, L, Nelson, M, Werner, B, Baron, R, Jackson, R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995;171:1053–1056.Google Scholar